• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue2

FECAL CALPROTECTIN AS INDICATOR OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL MALIGNANCY IN PATIENTS OF CHRONIC DIARRHEA

    Samer Nema Yassen Alkemawy1, Ahmed Jassim Al Koofee2, Hamza Shakir Kadhim3, Sadiq Jebbar ALMohana Yuldashev N. M.

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 6826-6830

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Calprotectin is consisting of a protein binding zinc and calcium mainly found in Neutrophils. It is generally associated with inflammation. Elevated fecal Calprotectin can be detected when there is gastric or colorectal malignancy, or when there is an inflammation such as in inflammatory bowel disease (Crohn's disease and ulcerative colitis). Objectives: To assess the role of fecal Calprotectin as an indicator for inflammatory bowel disease and malignancy in chronic diarrhea. Methodology: Cross-sectional study conducted in Al-Sadr Teaching Hospital from January till the end of March 2020, and included (100) patients with chronic diarrhea who underwent fecal Calprotectin test and colonoscopy. Results: Mean age of participants was (36.61 ± 13.09) years, with equal gender distribution. Comparison of fecal Calprotectin level among colonoscopy findings was performed using ANOVA test. There was significant association between the two variables (FCP and colonoscopy finding), P-value < 0.001. In Crohn's disease, fecal Calprotectin level was significantly higher than that of normal group, with a mean difference of (44.53) µg/g, P-value < 0.001. Similarly, ulcerative colitis had significantly higher fecal Calprotectin level than normal group with mean difference of (54.29) µg/g, P-value < 0.001. Conclusions: This study concludes that the level of fecal Calprotectin increases significantly in patients with inflammatory bowel disease and colon malignancy, and can be used to predict the abnormal findings in colonoscopy. However, this indicator cannot discriminate between ulcerative colitis and Crohn's disease.
Keywords:
  • PDF (446 K)
  • XML
(2020). FECAL CALPROTECTIN AS INDICATOR OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL MALIGNANCY IN PATIENTS OF CHRONIC DIARRHEA. European Journal of Molecular & Clinical Medicine, 7(2), 6826-6830.
Samer Nema Yassen Alkemawy1, Ahmed Jassim Al Koofee2, Hamza Shakir Kadhim3, Sadiq Jebbar ALMohana; Yuldashev N. M.. "FECAL CALPROTECTIN AS INDICATOR OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL MALIGNANCY IN PATIENTS OF CHRONIC DIARRHEA". European Journal of Molecular & Clinical Medicine, 7, 2, 2020, 6826-6830.
(2020). 'FECAL CALPROTECTIN AS INDICATOR OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL MALIGNANCY IN PATIENTS OF CHRONIC DIARRHEA', European Journal of Molecular & Clinical Medicine, 7(2), pp. 6826-6830.
FECAL CALPROTECTIN AS INDICATOR OF INFLAMMATORY BOWEL DISEASE AND INTESTINAL MALIGNANCY IN PATIENTS OF CHRONIC DIARRHEA. European Journal of Molecular & Clinical Medicine, 2020; 7(2): 6826-6830.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 59
  • PDF Download: 85
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus